Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.391 EUR | -2.37% | -1.01% | -15.00% |
07/05 | GenSight Biologics S.A. announced that it expects to receive ?1.546199 million in funding | CI |
05/04 | GenSight: financial visibility assured until the end of April | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.00% | 32.86M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- SIGHT Stock
- News GenSight Biologics S.A.
- GenSight Biologics Surges 63% as US Partner Manufactures Drug Substance for Lumevoq